anthonyyazdaniml/gliner-biomed-curated-corpus huggingface dataset:
Noncoding RNAs have been highlighted to be involved in the pathological process of ischemic stroke (IS). The purpose of this protocol will investigate the differentiated expression pattern of circular RNA (circRNA), long non-coding RNA (lncRNA) and micro-RNA (miRNA) by next-generation sequencing in acute ischemic stroke patients before and/or after endovascular treatment. The candidate circRNA/lncRNA/miRNA will be verified as the biomarker and regulator for progression and prognosis of acute ischemic stroke with endovascular treatment. Further, the candidate non-coding RNA will be used to evaluate the effect of endovascular treatment on both peripheral and central immune after stroke. Distinctive expression patterns of circRNA/miRNA/lncRNA will be identified by the next-generation sequencing and individual quantitative real time polymerase chain reaction (qRT-PCR). A predictive model will be established using logistic regression. The panel of these altered ncRNAs may be associated with the immune status after acute IS and could serve as a regulator for progression and prognosis of acute ischemic stroke with endovascular treatment.
The invention provides a structure capable of activating a cell apoptosis inducer. Based on the D-pi-A molecular skeleton, the cell scorch inducer can be activated by utilizing the intramolecular charge transfer mechanism (ICT) design. The photosensitivity can be effectively quenched by the protection of functional groups by taking nitroreductase, human quinone reductase (NQO 1), glutathione, hydrogen peroxide, superoxide anion free radical and the like as trigger groups and as protecting groups of phenolic hydroxyl groups. Can restore photosensitivity under the action of specific enzyme or active oxygen, and specifically cause the scorch of tumor cells. Therefore, not only can different activatable cell coke death inducers be customized according to the requirement and used for personalized treatment, but also can effectively activate anti-tumor immune response on the basis of reducing normal cell coke death injury. The invention has great application prospect in the aspects of personalized anti-tumor immunotherapy and the like.
The 11 control arm HR centres will be the placebo group. People who inject drugs (PWID) in this group will receive standard HR services, including to reduce abscesses if necessary. MONO-RUBs will not be made available in these HR centres during the intervention period.
Children and adolescents will perform 2 STS tests. First one is used to eliminate learning effect. Number of repetitions will be noted at the end of the second test.
Participants with first episode psychosis (FEP) recruited from First Episode Clinics in North Carolina (OASIS, Encompass, Eagle, and SHORE) or UNC-affiliated STEP Clinics (Carr Mill Mall, Vilcom Center, Main Wake Clinic) will participate in the online platform Horyzons for 3 months (cohort 1) or 6 months (cohort 2) as a part of their care plan. Participants will be encouraged to use both the therapeutic content and the moderated online community throughout their time in the study.
It has been reported that problems related to the musculoskeletal system, such as osteoarthritis, osteoporosis or spondylosis, increase with aging in elderly individuals. The Japanese Orthopedic Association (JOA) has defined this condition as locomotive syndrome (LS) in elderly individuals, as a condition of decreased mobility due to deterioration of locomotive organs. LS is a condition of reduced mobility due to deterioration of locomotive organs. It has been stated that the results of physical function and physical performance affecting locomotive syndrome in elderly individuals are controversial and studies are still needed. However, no studies have been found examining its relationship with the decrease in physical activity level, decline in cognitive functions, kinesiophobia (fear of movement) and fatigue seen in old age. Early detection of locomotive syndrome risk factors in elderly individuals will help prevent this condition, detect the risk of falling in elderly individuals and increase their quality of life. Based on these deficiencies, it is aimed to examine the relationship between locomotive syndrome and kinesiophobia, physical activity level, physical performance, fatigue and cognitive functions in elderly individuals.
BACKGROUND: Pompe disease, classified as glycogen storage disease type II, arises from a deficiency in the acid alpha-glucosidase (GAA) enzyme, leading to glycogen accumulation in multiple tissues. The unique correlation between genotype and enzyme activity is a key feature. This case highlights an infantile-onset form, emphasizing genetic counseling and prenatal testing importance.
CASE PRESENTATION: An 18-week-old infant with respiratory distress, cyanosis, and fever was admitted. Born healthy, her sibling died from Pompe disease. She presented with cardiomegaly, hypotonia, and absent reflexes. Diagnosis was confirmed by significantly reduced GAA activity. Despite treatment initiation, the patient succumbed to cardiac arrest.
CONCLUSIONS: The case underscores genetic counseling's role, offering insights into prenatal testing advancements, antenatal diagnosis through echocardiography, and the significance of early intervention, particularly in infantile-onset Pompe disease.
SYNOPSIS: Genetic risk assessment and prenatal testing are crucial for families with a history of Pompe disease to improve early diagnosis and management outcomes.
Steady-state serum concentrations of tricyclic antidepressants are reported to fluctuate significantly when cimetidine is either added or deleted from the drug regimen. Serious anticholinergic symptoms (severe dry mouth, urinary retention, blurred vision) have been associated with elevations in the serum levels of tricyclic antidepressants when cimetidine is added to the drug regimen. In addition, higher-than expected steady-state serum concentrations of tricyclic antidepressants have been observed when therapy is initiated in patients already taking cimetidine.

In well-controlled patients undergoing concurrent therapy with cimetidine, a decrease in the steady-state serum concentrations of tricyclic antidepressants may occur when cimetidine therapy is discontinued. The therapeutic efficacy of tricyclic antidepressants may be compromised in these patients when cimetidine is discontinued. Several of the tricyclic antidepressants have been cited in these reports.

There have been greater than 2-fold increases in previously stable plasma levels of other antidepressants, including nortriptyline, when fluoxetine hydrochloride has been administered in combination with these agents. Fluoxetine and its active metabolite, norfluoxetine, have long half-lives (4 to 16 days for norfluoxetine), that may affect strategies during conversion from one drug to the other.

Administration of reserpine during therapy with a tricyclic antidepressant has been shown to produce a “stimulating” effect in some depressed patients.

Close supervision and careful adjustment of the dosage are required when nortriptyline hydrochloride is used with other anticholinergic drugs or sympathomimetic drugs.

The patient should be informed that the response to alcohol may be exaggerated.
<P>PROBLEM TO BE SOLVED: To generate a simulation model adapted to the situation of an operation, from a medical image.  <P>SOLUTION: Geometric information is acquired from the medical image to construct volume data of a required internal organ. The volume data is operated to form the position and attitude of the internal organ specified by an operator, into a position and an attitude adapted to the operation. A blood vessel model connected to the specified internal organ is generated according to the position and attitude of the specified internal organ. A fat model of predetermined thickness is imparted around the predetermined internal organ included in the volume data in the connected state of the blood vessel model, to generate volume data. The internal organ in the generated volume data is then meshed. A template model of predetermined shape is operated using a template and arranged around the generated blood vessel model. A segment model is generated based on the arranged template model.  <P>COPYRIGHT: (C)2010,JPO&INPIT
This study proposes to evaluate the FDA-approved Radio Frequency Surgical Detection System (RFDS) as a non-radiological means to ease the process of detecting retained sponges and reconciling sponge counts in the labor and delivery room (following vaginal birth). It would not replace any of the current standard-of-care safety mechanisms already in place at the study site to prevent retained sponges. All safeguards remain enforced: counting, visual inspection, and x-rays if indicated by standard protocol. The system being studied involves the surgeon scanning the subject's vaginal area using a spherical device placed 1cm above the symphysis pubis. This static scan will serve to detect any retained cotton textiles within the vaginal cavity after birth. This Verisphere, a reusable device, is encased in a sterile sheath during use. It does not come into direct contact with the subject's vagina, but hovers above the pelvic/vaginal region. If any radio-frequency tagged sponges remain inside the subject, a signal alerts the surgical team to remove them. The visible console displays a confirmation code once the scan is complete. This confirmation code is kept as part of the medical record once absence of retained textiles is confirmed. Once the provider is assured there is no retained item, the same device may be used to scan trash receptacles to locate a missing textile if the pre- and post-delivery sponge/gauze count remains incongruent. This alleviates the need for the assistant personnel to manually "dig" through soiled materials for sponge localization.
Family-history assessment can identify individuals above population-risk for cancer to enable targeted Screening, Prevention and Early Detection (SPED). The online patient-facing cancer Family History Questionnaire Service (cFHQS) is a digitalised, resource efficient tool for family history data capture to facilitate this. The capturing of digital data from cFHQS allows for data interrogation of patients referred to Clinical Genetics for the purposes of service improvement. Digital data from 4,044 cFHQS respondents over a three-year period was collected and interrogated with respect to the number and type of familial tumour diagnoses to enable service improvement and streamlining of referral pathways. 81% of colorectal and 71% of breast screening assessments were population- or moderate-risk. Most patients who completed cFHQS reported more than one diagnosis of cancer/tumour/polyps in their family. 2.5% of family history assessment patients had a second indication that required assessment that would have been missed if single tumour type assessment was undertaken. Implementation of an innovative, digital family history data collection pathway has allowed large scale interrogation of referral patterns and assessment outcomes to enable service development. The high volume of inappropriate referrals to Clinical Genetics for population and moderate risk patients highlighted the need for dedicated secondary care pathway provision for these patients. The use of cFHQS streamlined family history assessment allows for redistribution of resources to improve equity and access to genetic cancer risk assessment.
BACKGROUND: The COVID-19 pandemic challenged the management of technical and human resources in intensive care units (ICU) across the world. Several long-term predictors for COVID-19 disease progression have been discovered. However, predictors to support short-term planning of resources and medication that can be translated to future pandemics are still missing. A workflow was established to identify a predictor for short-term COVID-19 disease progression in the acute phase of intensive care patients to support clinical decision-making.
METHODS: Thirty-two patients with SARS-CoV-2 infection were recruited on admission to the ICU and clinical data collected. During their hospitalization, plasma samples were acquired from each patient on multiple occasions, excepting one patient for which only one time point was possible, and the proteome (Inflammation, Immune Response and Organ Damage panels from Olink® Target 96), metabolome and lipidome (flow injection analysis and liquid chromatography-mass spectrometry) analyzed for each sample. Patient visits were grouped according to changes in disease severity based on their respiratory and organ function, and evaluated using a combination of statistical analysis and machine learning. The resulting short-term predictor from this multi-omics approach was compared to the human assessment of disease progression. Furthermore, the potential markers were compared to the baseline levels of 50 healthy subjects with no known SARS-CoV-2 or other viral infections.
RESULTS: A total of 124 clinical parameters, 271 proteins and 782 unique metabolites and lipids were assessed. The dimensionality of the dataset was reduced, selecting 47 from the 1177 parameters available following down-selection, to build the machine learning model. Subsequently, two proteins (C-C motif chemokine 7 (CCL7) and carbonic anhydrase 14 (CA14)) and one lipid (hexosylceramide 18:2; O2/20:0) were linked to disease progression in the studied SARS-CoV-2 infections. Thus, a predictor delivering the prognosis of an upcoming worsening of the patient's condition up to five days in advance with a reasonable accuracy (79 % three days prior to event, 84 % four to five days prior to event) was found. Interestingly, the predictor's performance was complementary to the clinicians' capabilities to foresee a worsening of a patient.
CONCLUSION: This study presents a workflow to identify omics-based biomarkers to support clinical decision-making and resource management in the ICU. This was successfully applied to develop a short-term predictor for aggravation of COVID-19 symptoms. The applied methods can be adapted for future small cohort studies.
The invention discloses bullfrog slow-excitation peptide, coded nucleic acid thereof and application. The bullfrog slow-excitation peptide is composed of nine parts of amino acid, the molecular weight is 1043.2 daltons, the isoelectric point is 9.50, and the amino acid sequence is SEQ ID NO. 4: Arg Pro Pro Gly Cys Asn Pro Phe Arg. The sequence of the encoded gene of the bullfrog slow-excitation peptide is the 156-183th nucleotide of the sequence shown by the SEQ ID NO.1. The bullfrog slow-excitation peptide is composed of sixteen parts of amino acid, the molecular weight is 1759.0 daltons, the isoelectric point is 10.35, and the sequence of the amino acid is SEQ ID NO. 6: Arg Pro Pro Gly Cys Asn Pro Phe Arg Ile Ala Pro Ala Ser Tyr Leu. According to the bullfrog slow-excitation peptide, the coded nucleic acid thereof and the application, the amino acid structure of the bullfrog slow-excitation peptide is deduced through the coded gene of the bullfrog slow-excitation peptide, and the synthetic bullfrog slow-excitation peptide RR9 and RL16 have very strong activity for promoting contraction of in-vitro ileum muscle of rats. The bullfrog slow-excitation peptide has the advantages of being simple in structure and convenient to synthesize artificially, so that the bullfrog slow-excitation peptide can serve as cardio-cerebral-vascular drug and application of medicine for promoting intestinal contraction.
Diabetic retinopathy is not cured efficiently and changes of lifestyle measures may delay early retinal injury in diabetes. The aim of our study was to investigate the effects of reduced daily light exposure on retinal vascular changes in streptozotocin (STZ)-induced model of DM with emphasis on inflammation, Aqp4 expression, visual cycle and cholesterol metabolism-related gene expression in rat retina and RPE. Male Wistar rats were divided into the following groups: 1. control; 2. diabetic group (DM) treated with streptozotocin (100 mg/kg); 3. group exposed to light/dark cycle 6/18 h (6/18); 4. diabetic group exposed to light/dark cycle 6/18 h (DM+6/18). Retinal vascular abnormalities were estimated based on lectin staining, while the expression of genes involved in the visual cycle, cholesterol metabolism, and inflammation was determined by qRT-PCR. Reduced light exposure alleviated vasculopathy, gliosis and the expression of IL-1 and TNF-α in the retina with increased perivascular Aqp4 expression. The expression of genes involved in visual cycle and cholesterol metabolism was significantly up-regulated in RPE in DM+6/18 vs. DM group. In the retina only the expression of APOE was significantly higher in DM+6/18 vs. DM group. Reduced light exposure mitigates vascular changes and gliosis in DM via its anti-inflammatory effect, increased retinal cholesterol turnover and perivascular Aqp4 expression.
Most organisms possess endogenous circadian clocks that synchronise their physiology and behaviour with environmental cycles, with the light-dark (LD) cycle being the most potent synchronising signal. Consequently, it can be hypothesised that animals that have evolved in the dark, as in caves or deep sea, may no longer possess a functional light-entrained biological clock. In this research, the blind cavefish Astyanax mexicanus was selected as a model organism to investigate the potential effects of daily light conditions on the circadian timekeeping mechanisms. First, we focused on describing behavioural photic entrainment and the presence of a circadian endogenous rhythmicity by recording locomotor activity rhythms under different lighting regimes: LD 12:12, after a 6-h shift of LD, constant darkness (DD), and constant dim light (LLdim). Secondly, we aimed at characterising the mechanisms of photodetection by analysing the daily rhythms of expression of selected non-visual extraocular opsins (exo-rhod, opn3, rgra, rgrb, tmt1a and tmt1b) in the brain of this blind species using real-time quantitative PCR. Our results revealed that blind Mexican cavefish activity rhythms were entrained to the LD cycle, with a diurnal activity pattern that persisted in a circadian fashion under constant lighting conditions. Additionally, statistically significant daily variations and/or rhythms were observed in three out of the six non-visual opsin genes analysed (opn3, rgra and tmt1b), all of them displaying nocturnal acrophases. These findings suggest that daily rhythms in extraretinal non-visual opsins may be transducing daily photic cycles and contributing to the entrainment of locomotor activity and other light-synchronised rhythms in blind cavefish species.
The invention aims to provide a traditional Chinese medicine extract with heat-clearing, detoxifying, antibacterial and anti-inflammatory functions. The traditional Chinese medicine extract with the heat-clearing, detoxifying, antibacterial and anti-inflammatory functions is prepared by extracting the following medicine raw materials of radix scutellariae, dandelion, herba corydalis bungeanae and isatis root through a scientific and reasonable process method, wherein the mass ratio of radix scutellariae to dandelion to herba corydalis bungeanae to isatis root is (1-3): (3-5):(0.5-2):(1-3). The traditional Chinese medicine extract with the heat-clearing, detoxifying, antibacterial and anti-inflammatory functions has the advantages the impurity ingredients in the medicine materials are maximumly removed, the effective ingredients are fully remained, and the heat-clearing, detoxifying, antibacterial and anti-inflammatory effects are realized. The invention also discloses four preparations containing the traditional Chinese medicine extract with the heat-clearing, detoxifying, antibacterial and anti-inflammatory functions, i.e. syrup, mixture, buccal tablet and dripping pill. The four preparations have the advantages that the heat-clearing, detoxifying, antibacterial and anti-inflammatory functions are realized, the preparations can be clinically used for preventing and controlling diseases, such as furuncle, pharyngitis, parotitis, lymphadenitis and tonsillitis, the content of effective ingredients is high, the dosage is small, the preparations are stable, and the therapeutic effect is good. The invention also provides a quality control method of the preparations containing the traditional Chinese medicine extract with the heat-clearing, detoxifying, antibacterial and anti-inflammatory functions.
The invention discloses a traditional Chinese medicine composition for treating hyperthyroidism. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 25 to 35 parts of radix astragali, 8 to 12 parts of pseudostellaria root, 8 to 12 parts of rehmanniae radix, 8 to 12 parts of white Chinese peony, 8 to 12 parts of Chinese magnoliavine, 8 to 12 parts of prunella vulgaris, 8 to 12 parts of fried jujube kernel, 20 to 30 parts of raw dragon bone, 8 to 12 parts of pinellia ternate, and 8 to 12 parts of dried orange peel. The traditional Chinese medicine composition for treating hyperthyroidism is prepared by compounding 10 natural traditional Chinese herbals. The raw materials can generate a synergetic effect. The composition has the functions of clear heat, cooling blood, regulating qi, invigorating the spleen, nourishing yin, moistening the lung, calming the liver and suppressing yang, treats both the symptoms and roots, has a good effect on treating hyperthyroidism, and does not have any side or toxic effect. Furthermore, the preparation method is simple, the treatment course is short, the composition is user-friendly, the cost is low, and the effective rate can reach more than 80%.
The plant apoplast, which serves as the frontline battleground for long-term host-pathogen interactions, harbors a wealth of disease resistance resources. However, the identification of the disease resistance proteins in the apoplast is relatively lacking. In this study, we identified and characterized the rice secretory protein OsSSP1 (Oryza sativa secretory small protein 1). OsSSP1 can be secreted into the plant apoplast, and either in vitro treatment of recombinant OsSSP1 or overexpression of OsSSP1 in rice could trigger plant immune response. The expression of OsSSP1 is suppressed significantly during Magnaporthe oryzae infection in the susceptible rice variety Taibei 309, and OsSSP1-overexpressing lines all show strong resistance to M. oryzae. Combining the knockout and overexpression results, we found that OsSSP1 positively regulates plant immunity in response to fungal infection. Moreover, the recognition and immune response triggered by OsSSP1 depend on an uncharacterized transmembrane OsSSR1 (secretory small protein receptor 1) and the key co-receptor OsBAK1, since most of the induced immune response and resistance are lost in the absence of OsSSR1 or OsBAK1. Intriguingly, the OsSSP1 protein is relatively stable and can still induce plant resistance after 1 week of storage in the open environment, and exogenous OsSSP1 treatment for a 2-week period did not affect rice yield. Collectively, our study reveals that OsSSP1 can be secreted into the apoplast and percepted by OsSSR1 and OsBAK1 during fungal infection, thereby triggering the immune response to enhance plant resistance to M. oryzae. These findings provide novel resources and potential strategies for crop breeding and disease control.
In the intervention arm, 300 shockwave impulses per coronary supply territory, at an energy flux density of 0.38mJ/mm2 and a frequency 3Hz, are applied in direct contact with the ischaemic myocardium of the left ventricle. The intervention is performed during CABG surgery after bypasses are fully established while still on cardiopulmonary bypass.
Participants in this arm will receive a placebo. The intervention includes taking 2 ml of the placebo directly onto the tongue every evening, 1-2 hours before bedtime, for a duration of 8 weeks.